Outcomes of patients with therapy-related myeloid neoplasms after treatment with poly(ADP-ribose) polymerase proteins inhibitors for solid tumours

被引：6

作者：

Almanza-Huante, Emmanuel ^{[1
]}

Bataller, Alex ^{[1
]}

Urrutia, Samuel ^{[2
]}

Gener-Ricos, Georgina ^{[1
]}

Briski, Robert Edward ^{[1
]}

Kanagal-Shamanna, Rashmi ^{[3
]}

Lu, Karen H. ^{[4
]}

Westin, Shannon N. ^{[4
]}

Yap, Timothy A. ^{[5
]}

Takahashi, Koichi ^{[1
]}

Ravandi, Farhad ^{[1
]}

Alvarado, Yesid ^{[1
]}

Kadia, Tapan ^{[1
]}

Sasaki, Koiji ^{[1
]}

Kantarjian, Hagop M. ^{[1
]}

Garcia-Manero, Guillermo ^{[1
]}

机构：

[1] Univ Texas Houston, Dept Leukemia, MD Anderson Canc Ctr, 1515 Holcombe Blvd, Houston, TX 77030 USA

[2] Univ Texas Houston, Canc Med, MD Anderson Canc Ctr, Houston, TX USA

[3] Univ Texas Houston, Dept Hematopathol, MD Anderson Canc Ctr, Houston, TX USA

[4] Univ Texas Houston, Dept Gynecol Oncol & Reprod Med, MD Anderson Canc Ctr, Houston, TX USA

[5] Univ Texas Houston, Dept Invest Canc Therapeut, Phase Program 1, MD Anderson Canc Ctr, Houston, TX USA

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2023年 / 201卷 / 03期

关键词：

PARP inhibitors; therapy related myeloid neoplasms; therapy-related acute myeloid leukaemia; therapy-related myelodysplastic syndrome; LEUKEMIA; PARP;

D O I：

10.1111/bjh.18766

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E25 / E29

页数：5

共 13 条

[1]

Bernard Elsa, 2022, NEJM Evid, V1, pEVIDoa2200008, DOI 10.1056/EVIDoa2200008

[2] Therapy-Related Myeloid Neoplasms [J].

Bueso-Ramos, Carlos E. ;

Kanagal-Shamanna, Rashmi ;

Routbort, Mark J. ;

Hanson, Curtis A. .

AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 (02) :207-218

[3] PARP Inhibitors and Myeloid Neoplasms: A Double-Edged Sword [J].

Csizmar, Clifford M. ;

Saliba, Antoine N. ;

Swisher, Elizabeth M. ;

Kaufmann, Scott H. .

CANCERS, 2021, 13 (24)

[4] Revised International Prognostic Scoring System for Myelodysplastic Syndromes [J].

Greenberg, Peter L. ;

Tuechler, Heinz ;

Schanz, Julie ;

Sanz, Guillermo ;

Garcia-Manero, Guillermo ;

Sole, Francesc ;

Bennett, John M. ;

Bowen, David ;

Fenaux, Pierre ;

Dreyfus, Francois ;

Kantarjian, Hagop ;

Kuendgen, Andrea ;

Levis, Alessandro ;

Malcovati, Luca ;

Cazzola, Mario ;

Cermak, Jaroslav ;

Fonatsch, Christa ;

Le Beau, Michelle M. ;

Slovak, Marilyn L. ;

Krieger, Otto ;

Luebbert, Michael ;

Maciejewski, Jaroslaw ;

Magalhaes, Silvia M. M. ;

Miyazaki, Yasushi ;

Pfeilstoecker, Michael ;

Sekeres, Mikkael ;

Sperr, Wolfgang R. ;

Stauder, Reinhard ;

Tauro, Sudhir ;

Valent, Peter ;

Vallespi, Teresa ;

van de Loosdrecht, Arjan A. ;

Germing, Ulrich ;

Haase, Detlef .

BLOOD, 2012, 120 (12) :2454-2465

[5] Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide [J].

Kayser, S. ;

Krzykalla, J. ;

Elliott, M. A. ;

Norsworthy, K. ;

Gonzales, P. ;

Hills, R. K. ;

Baer, M. R. ;

Racil, Z. ;

Mayer, J. ;

Novak, J. ;

Zak, P. ;

Szotkowski, T. ;

Grimwade, D. ;

Russell, N. H. ;

Walter, R. B. ;

Estey, E. H. ;

Westermann, J. ;

Goerner, M. ;

Benner, A. ;

Kraemer, A. ;

Smith, B. D. ;

Burnett, A. K. ;

Thiede, C. ;

Roellig, C. ;

Ho, A. D. ;

Ehninger, G. ;

Schlenk, R. F. ;

Tallman, M. S. ;

Levis, M. J. ;

Platzbecker, U. .

LEUKEMIA, 2017, 31 (11) :2347-2354

[6] Therapy-related myeloid neoplasms [J].

Larson, Richard A. .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (04) :454-459

[7] PARP inhibitors: Synthetic lethality in the clinic [J].

Lord, Christopher J. ;

Ashworth, Alan .

SCIENCE, 2017, 355 (6330) :1152-1158

[8] Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights [J].

Martin, J. E. ;

Khalife-Hachem, S. ;

Grinda, T. ;

Kfoury, M. ;

Garciaz, S. ;

Pasquier, F. ;

Vargaftig, J. ;

Uzunov, M. ;

Belhabri, A. ;

Bertoli, S. ;

Cotteret, S. ;

Verge, V. ;

Renneville, A. ;

Rosselli, F. ;

Antony-Debre, I. ;

Rouleau, E. ;

Salviat, F. ;

Caron, O. ;

Delaloge, S. ;

Pautier, P. ;

Etienne, G. ;

Recher, C. ;

Vey, N. ;

De Botton, S. ;

Leary, A. ;

Marzac, C. ;

Micol, J. B. .

ANNALS OF ONCOLOGY, 2021, 32 (08) :1046-1048

[9] Myelodysplastic syndrome and acute myeloid leukaemia in patients treated with PARP inhibitors: a safety meta-analysis of randomised controlled trials and a retrospective study of the WHO pharmacovigilance database [J].

Morice, Pierre-Marie ;

Leary, Alexandra ;

Dolladille, Charles ;

Chretien, Basile ;

Poulain, Laurent ;

Gonzalez-Martin, Antonio ;

Moore, Kathleen ;

O'Reilly, Eileen Mary ;

Ray-Coquard, Isabelle ;

Alexandre, Joachim .

LANCET HAEMATOLOGY, 2021, 8 (02) :e122-e134

[10] Comparison of therapy-related and de novo core binding factor acute myeloid leukemia: A bone marrow pathology group study [J].

Rogers, Heesun J. ;

Wang, Xiaoqiong ;

Xie, Yan ;

Davis, Adam R. ;

Thakral, Beenu ;

Wang, Sa A. ;

Borthakur, Gautam ;

Cantu, Miguel D. ;

Margolskee, Elizabeth M. ;

Philip, John K. S. ;

Sukhanova, Madina ;

Bagg, Adam ;

Bueso-Ramos, Carlos E. ;

Orazi, Attilio ;

Arber, Daniel A. ;

Hsi, Eric D. ;

Hasserjian, Robert P. .

AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (07) :799-808

← 1 2 →